Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Boykin, C, Zhang, G, Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/
http://dx.doi.org/10.1038/bjc.2012.77
_version_ 1782226902821371904
author Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
author_facet Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
author_sort Boykin, C
collection PubMed
description
format Online
Article
Text
id pubmed-3304433
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-33044332012-03-16 Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation Boykin, C Zhang, G Chen, Y-H Zhang, R-W Fan, X-E Yang, W-M Lu, Q Br J Cancer Corrigendum Nature Publishing Group 2012-03-13 2012-03-13 /pmc/articles/PMC3304433/ http://dx.doi.org/10.1038/bjc.2012.77 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Corrigendum
Boykin, C
Zhang, G
Chen, Y-H
Zhang, R-W
Fan, X-E
Yang, W-M
Lu, Q
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_full Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_fullStr Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_full_unstemmed Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_short Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
title_sort cucurbitacin iia: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of jak2/stat3 phosphorylation
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304433/
http://dx.doi.org/10.1038/bjc.2012.77
work_keys_str_mv AT boykinc cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT zhangg cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT chenyh cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT zhangrw cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT fanxe cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT yangwm cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation
AT luq cucurbitaciniiaanovelclassofanticancerdruginducingnonreversibleactinaggregationandinhibitingsurvivinindependentofjak2stat3phosphorylation

Ejemplares similares